Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality Enhancement Research Initiative (QERI) in the Dyslipidemia Management Strategy Involving Ezetimibe With Statin in High Risk Patients Who Have Not Achieved Recommended LDL Targets

NCT00408057 is registered in ClinicalTrials.gov with Canadian Heart Research Centre as lead sponsor.

NCT NCT00408057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00408057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality Enhancement Research Initiative (QERI) in the Dyslipidemia Management Strategy Involving Ezetimibe With Statin in High Risk Patients Who Have Not Achieved Recommended LDL Targets
Lead sponsor
Canadian Heart Research Centre
Phase
Observational
Overall status
Completed
Start date
December 31, 2005
Completion date
November 30, 2007
Enrollment
2,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases